{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:28:22Z","timestamp":1793899702317,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-9\/2021-14\/200110"],"award-info":[{"award-number":["451-03-9\/2021-14\/200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-47\/2022-01\/200110"],"award-info":[{"award-number":["451-03-47\/2022-01\/200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-47\/2023-01\/200110"],"award-info":[{"award-number":["451-03-47\/2023-01\/200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-66\/2024-03\/200110"],"award-info":[{"award-number":["451-03-66\/2024-03\/200110"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kedrion Biopharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00415-026-14106-3","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:25:51Z","timestamp":1790537151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of leukocyte p38 MAP kinase in immune-mediated peripheral polyneuropathies: distinct modulation by intravenous immunoglobulins"],"prefix":"10.1007","volume":"273","author":[{"given":"Marina","family":"Stamenkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Vukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Milosevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stojan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Paunic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Anicin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Bozovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksa","family":"Palibrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vukan","family":"Ivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Trajkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4912-7761","authenticated-orcid":false,"given":"Verica","family":"Paunovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"14106_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2147\/ndt.s39592","volume":"10","author":"VH Lawson","year":"2014","unstructured":"Lawson VH, Arnold WD (2014) Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment. Neuropsychiatr Treat 10:567\u2013576. https:\/\/doi.org\/10.2147\/ndt.s39592","journal-title":"Neuropsychiatr Treat"},{"key":"14106_CR2","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1007\/s00415-018-9071-9","volume":"265","author":"WN L\u00f6scher","year":"2018","unstructured":"L\u00f6scher WN, Oberreiter EM, Erdler M et al (2018) Multifocal motor neuropathy in Austria: a nationwide survey of clinical features and response to treatment. J Neurol 265:2834\u20132840. https:\/\/doi.org\/10.1007\/s00415-018-9071-9","journal-title":"J Neurol"},{"key":"14106_CR3","unstructured":"Van den Bergh PA-O, van Doorn PA-O, Hadden RA-O, et al. European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision"},{"key":"14106_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mayocpiqo.2023.12.002","volume":"8","author":"JA Allen","year":"2024","unstructured":"Allen JA, Clarke AE, Harbo T (2024) A practical guide to identify patients with multifocal motor neuropathy, a treatable immune-mediated neuropathy. Mayo Clin Proc Innov Qual Outcomes 8:74\u201381. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2023.12.002","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"14106_CR5","unstructured":"Hu J, Zhao C, Lin J. Potential therapeutic strategies in chronic inflammatory demyelinating polyradiculoneuropathy"},{"key":"14106_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mus.28349","volume":"71","author":"B Claytor","year":"2025","unstructured":"Claytor B, Polston D, Li Y (2025) Multifocal motor neuropathy: a narrative review. Muscle Nerve 71:512\u2013534. https:\/\/doi.org\/10.1002\/mus.28349","journal-title":"Muscle Nerve"},{"key":"14106_CR7","volume-title":"StatPearls [Internet]","author":"S Hameed","year":"2023","unstructured":"Hameed S, Cascella M (2023) Multifocal motor neuropathy. StatPearls [Internet]. StatPearls Publishing"},{"key":"14106_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010369.pub2","volume":"1","author":"AL Oaklander","year":"2017","unstructured":"Oaklander AL, Lunn MP, Hughes RA et al (2017) Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev 1:Cd010369. https:\/\/doi.org\/10.1002\/14651858.CD010369.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"14106_CR9","unstructured":"Briani CA-O, Cocito D, Campagnolo M, et al. Update on therapy of chronic immune-mediated neuropathies"},{"key":"14106_CR10","unstructured":"Chang L, Karin M. Mammalian MAP kinase signalling cascades"},{"key":"14106_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","volume":"20","author":"C Dong","year":"2002","unstructured":"Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20:55\u201372. https:\/\/doi.org\/10.1146\/annurev.immunol.20.091301.131133","journal-title":"Annu Rev Immunol"},{"key":"14106_CR12","unstructured":"Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system"},{"key":"14106_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neulet.2004.09.016","volume":"372","author":"M Ahn","year":"2004","unstructured":"Ahn M, Moon C, Lee Y et al (2004) Activation of extracellular signal-regulated kinases in the sciatic nerves of rats with experimental autoimmune neuritis. Neurosci Lett 372:57\u201361. https:\/\/doi.org\/10.1016\/j.neulet.2004.09.016","journal-title":"Neurosci Lett"},{"key":"14106_CR14","unstructured":"Ahn M, Shin T. Increased phosphorylation of c-Jun NH (2)-terminal protein kinase in the sciatic nerves of Lewis rats with experimental autoimmune neuritis"},{"key":"14106_CR15","unstructured":"Moon C, Ahn M, Fau Kim H, Kim H F, Lee Y, et al. Activation of p38 mitogen-activated protein kinase in the early and peak phases of autoimmune neuritis in rat sciatic nerves"},{"key":"14106_CR16","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168:960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"key":"14106_CR17","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1002\/art.40223","volume":"69","author":"A Perl","year":"2017","unstructured":"Perl A (2017) Review: metabolic control of immune system activation in rheumatic diseases. Arthritis Rheumatol 69:2259\u20132270. https:\/\/doi.org\/10.1002\/art.40223","journal-title":"Arthritis Rheumatol"},{"key":"14106_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/wnr.0000000000000543","volume":"27","author":"S Zhou","year":"2016","unstructured":"Zhou S, Chen X, Xue R et al (2016) Autophagy is involved in the pathogenesis of experimental autoimmune neuritis in rats. NeuroReport 27:337\u2013344. https:\/\/doi.org\/10.1097\/wnr.0000000000000543","journal-title":"NeuroReport"},{"key":"14106_CR19","doi-asserted-by":"publisher","unstructured":"Paunovic VA-O, Peric SA-OX, Vukovic I, et al. Downregulation of LKB1\/AMPK Signaling in Blood Mononuclear Cells Is Associated with the Severity of Guillain-Barre Syndrome. LID - https:\/\/doi.org\/10.3390\/cells11182897 LID - 2897","DOI":"10.3390\/cells11182897"},{"key":"14106_CR20","unstructured":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision"},{"key":"14106_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4155\/fmc-2016-0210","volume":"9","author":"L Gao","year":"2017","unstructured":"Gao L, Jauregui CE, Teng Y (2017) Targeting autophagy as a strategy for drug discovery and therapeutic modulation. Future Med Chem 9:335\u2013345. https:\/\/doi.org\/10.4155\/fmc-2016-0210","journal-title":"Future Med Chem"},{"key":"14106_CR22","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","volume":"28","author":"PYK Van den Bergh","year":"2021","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM et al (2021) European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force\u2014second revision. Eur J Neurol 28:3556\u20133583. https:\/\/doi.org\/10.1111\/ene.14959","journal-title":"Eur J Neurol"},{"key":"14106_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/mus.24207","volume":"50","author":"A Breiner","year":"2014","unstructured":"Breiner A, Barnett C, Bril V (2014) Incat disability score: a critical analysis of its measurement properties. Muscle Nerve 50:164\u2013169. https:\/\/doi.org\/10.1002\/mus.24207","journal-title":"Muscle Nerve"},{"key":"14106_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","volume":"72","author":"IS Merkies","year":"2002","unstructured":"Merkies IS, Schmitz PI, van der Mech\u00e9 FG et al (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72:596\u2013601. https:\/\/doi.org\/10.1136\/jnnp.72.5.596","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14106_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-2-8","volume":"2","author":"RJ Feise","year":"2002","unstructured":"Feise RJ (2002) Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol 2:8. https:\/\/doi.org\/10.1186\/1471-2288-2-8","journal-title":"BMC Med Res Methodol"},{"key":"14106_CR26","unstructured":"McCombe PA, Hardy TA, Nona RJ, et al. Sex differences in Guillain Barr\u00e9 syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis"},{"key":"14106_CR27","unstructured":"Gold R, Hartung Hp F, Toyka KV, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system"},{"key":"14106_CR28","unstructured":"Wang L, Gu T, Yu C, et al. Kaempferol attenuates experimental autoimmune neuritis through TNFR1\/JNK\/p38 signaling pathway inhibition"},{"key":"14106_CR29","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1474-4422(24)00073-5","volume":"23","author":"R Tawil","year":"2024","unstructured":"Tawil R, Wagner KR, Hamel JI et al (2024) Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol 23:477\u2013486. https:\/\/doi.org\/10.1016\/S1474-4422(24)00073-5","journal-title":"Lancet Neurol"},{"key":"14106_CR30","unstructured":"Zhou C, Huang M, Xie L, et al. IVIG inhibits TNF-\u03b1-induced MMP9 expression and activity in monocytes by suppressing NF-\u03baB and P38 MAPK activation"},{"key":"14106_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2249-y","volume":"11","author":"M Das","year":"2020","unstructured":"Das M, Karnam A, Stephen-Victor E et al (2020) Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy. Cell Death Dis 11:50. https:\/\/doi.org\/10.1038\/s41419-020-2249-y","journal-title":"Cell Death Dis"},{"key":"14106_CR32","unstructured":"Kim MA-O, Choe YA-O, Lee SA-O. Lessons from the success and failure of targeted drugs for rheumatoid arthritis: perspectives for effective basic and translational research"},{"key":"14106_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2174\/1568026054985911","volume":"5","author":"DM Dambach","year":"2005","unstructured":"Dambach DM (2005) Potential adverse effects associated with inhibition of p38\u03b1\/\u03b2 MAP kinases. Curr Top Med Chem 5:929\u2013939. https:\/\/doi.org\/10.2174\/1568026054985911","journal-title":"Curr Top Med Chem"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14106-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14106-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14106-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:05:50Z","timestamp":1793898350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14106-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14106"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14106-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper\n                      .","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of the Faculty of Medicine, University of Belgrade (permit no.\u00a02650\/XII-4) and the Ethical Board of the University Clinical Centre of Serbia (permit no.\u00a095\/34). The datasets used and\/or analyzed during the current study are available from the corresponding author on reasonable request. Raw data of immunoblot images are submitted as supplemental material. The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"627"}}